Meds IQ | E-Learning | Safe prescribing

Children and young people's medicines - learning@lunch

Course summary

This learning programme is an opportunity for a department or learning community to come together as a group and discuss the topic of children and young people's medicines. During the programme you get to reflect on your current practice and how you may be able to change your practice and influence others.

Aims and objectives

The aim of this programme is to provide a better understanding of your role in the management of medicines for children and young people in hospital and primary care settings.


Book 1 of the programme is provided as pre-reading for the session in which your group will come together. This will provide everyone with the required background knowledge and appropriate reflection on their current practice. This will take approximately 5 hours in total.Book 2 is provided at the session when you and your colleagues come together. During this time you will pick 1 to 2 case studies, that suit your group best, to work through and feedback and discuss as a group. This session should take no longer than an hour - the time it takes to have lunch!It helps the running of these sessions to have a designated lead for the session, also known as the facilitator. This person can set up the session and lead the session. They will be provided with a facilitators guide which provides helpful hints.

Learning outcomes

On completion of all aspects of this learning programme you should be able to:

  • appraise the evidence base for paediatric medicine
  • determine which reference sources to use for specific situations in medicines management for children and young people
  • demonstrate an understanding of licensing and formulation issues that must be considered when dealing with medicines for children and young people
  • apply the appropriate dose adjustments for the development age, stage and circumstance of the child or young person
  • discuss the factors affecting medicines adherence in children and young people
  • find solutions to some of the key issues affecting medicines administration and management in schools.
Quality assurance/MHRA Registration

All CPPE programmes undergo a rigorous QA process where highly skilled learning development pharmacists review each programme and topic experts review the programme for clinical accuracy. In this programme members of the Neonatal and Paediatric Pharmacists Group (NPPG) were involved.Every CPPE programme is funded by NHS Health Education England.